BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 19, 2005
View Archived Issues
European orphan drug designation for NAFB-001
Read More
NVA-237 enters phase IIb trial for COPD
Read More
Cand5 begins phase II for wet AMD
Read More
Tysabri safety evaluation completed with no new cases of PML
Read More
Results for Neugene compounds in Ebola, Marburg, anthrax and ricin models
Read More
New pivotal study for ceftobiprole to broaden indication
Read More
Trigen completes financing in support of pipeline development
Read More
5-HT2A receptor antagonists from Sankyo prove to be beneficial for pancreatitis
Read More
SM-197378 reduces myocardial infarct size in vivo
Read More
Confirmation of SSR-149415's antidepressant potential
Read More
Artemisinin combination therapies for malaria
Read More
BioCryst files SPA for Fodosine trial in relapsed or refractory T-cell leukemia
Read More
MedImmune completes acquisition of Cellective Therapeutics
Read More
Agensys and Merck to codevelop and commercialize AGS-PSCA for cancer
Read More
MLN-518 begins phase I/II study with chemotherapy for AML
Read More
Nastech begins development of intranasal rapid-acting insulin
Read More
Kissei seeks Japanese approval for Glufast with alpha-glucosidase inhibitor
Read More
New title added to the Drug R&D Backgrounders topic list --Osteogenesis Imperfecta
Read More
Novel FXR agonists emerge from Intercept R&D
Read More
Recent patents describe novel antiinfective agents
Read More
Preliminary phase II data on the antitumor efficacy of AS-1404 in lung cancer announced
Read More
Phase III data on Polyphenon E in the treatment of external anogenital warts
Read More
M01ZH09 typhoid vaccine reported safe and immunogenic in human volunteers
Read More
Altana patents claim gastric acid antisecretory agents
Read More
Abatacept effective in refractory rheumatoid arthritis
Read More
PROVE IT-TIMI 22 studies detail benefits of statins in acute coronary syndromes
Read More